RS

Ranjan Sarkar

Active Director Director DIN 09459714
DIN 09459714 First appointment Jan 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Ranjan Sarkar

Data last updated:

Ranjan Sarkar is a Director at Pharmacommit Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Pharmacommit Pharmaceuticals Private Limited reported revenue of ₹1.6 Lakh (FY 2024).

DIN 09459714
Primary Designation Director
Industry Chemicals
First Appointment 06 Jan 2022
Oldest Company Age 4 yrs
Largest company Pharmacommit Pharmaceuticals Private Limited · ₹1.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jan 20222022₹1.6 Lakh (FY 2024)Active

Board colleagues of Ranjan Sarkar

Directorship timeline

Open interactive timeline →
Pharmacommit Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ranjan Sarkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjan Sarkar

Ranjan Sarkar currently holds 1 directorship: Pharmacommit Pharmaceuticals Private Limited (Director, since 06 Jan 2022, revenue ₹1.6 Lakh (FY 2024)).

Ranjan Sarkar was first appointed on 06 Jan 2022 as Director at Pharmacommit Pharmaceuticals Private Limited.

The current boards of Ranjan Sarkar's companies include Chandradeep Sarkar (Pharmacommit Pharmaceuticals Private Limited), Usha Rani Sarkar (Pharmacommit Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available